Four Tier 2 and one tier 3 medicine supply notifications have been issued for the following items:
Tier 2
- Estradiol (Estradot) 75micrograms/24hours transdermal patches
- Estriol (Imvaggis) 0.03mg pessary
- Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions
- Alfuzosin 10mg modified release tablets
Tier 3
- Oxycodone Hydrochloride 5mg/5ml Oral Solution
| Medicine | Out of stock | Alternatives |
| Estradiol (Estradot) 75micrograms/24hours transdermal patches | Until early May 2023
| Evorel 75micrograms/24hours transdermal patches See MSN for details.
|
| Estriol (Imvaggis) 0.03mg pessary | Until mid-late May 2023 | Alternative estriol vaginal products Estradiol 10mcg vaginal tablets |
| Alfuzosin 10mg modified release tablets | Until w/c 15 May 2023
| Alternative alpha-adrenoceptor blockers are available See MSN for details
|
| Oxycodone Hydrochloride 5mg/5ml Oral Solution | Until end of June 2023 | Oxycodone 5mg and 10mg immediate release capsules Alternative liquid opioid formulations Specials oxycodone 5mg/5ml oral suspension have been sourced. See MSN for details |
| Clarithromycin 125mg/5ml oral suspension Clarithromycin 250mg/5ml oral suspension | 125mg/5ml oral suspension – until w/c 10 April 2023 250mg/5ml oral suspension – limited supply until w/c 10 April 2023 | Alternative clarithromycin preparations Serious Shortage Protocol’s (SSP) were issued on 06/04/2023 See MSN |
Up-to-date information about medicine supply issues is available via the online Medicines Supply Tool (SPS registration required)